ALTERED FOS-LIKE IMMUNOREACTIVITY IN TERMINAL REGIONS OF THE MESOTELENCEPHALIC DOPAMINE SYSTEM IS ASSOCIATED WITH REAPPEARANCE OF TYROSINE-HYDROXYLASE IMMUNOREACTIVITY AT THE SITES OF FOCAL 6-HYDROXYDOPAMINE LESIONS IN THE NUCLEUS-ACCUMBENS

Citation
Ma. Chapman et Ds. Zahm, ALTERED FOS-LIKE IMMUNOREACTIVITY IN TERMINAL REGIONS OF THE MESOTELENCEPHALIC DOPAMINE SYSTEM IS ASSOCIATED WITH REAPPEARANCE OF TYROSINE-HYDROXYLASE IMMUNOREACTIVITY AT THE SITES OF FOCAL 6-HYDROXYDOPAMINE LESIONS IN THE NUCLEUS-ACCUMBENS, Brain research, 736(1-2), 1996, pp. 270-279
Citations number
40
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
00068993
Volume
736
Issue
1-2
Year of publication
1996
Pages
270 - 279
Database
ISI
SICI code
0006-8993(1996)736:1-2<270:AFIITR>2.0.ZU;2-E
Abstract
The present study was undertaken in order to determine whether unilate ral 6-hydroxydopamine (6-OHDA) lesions in the nucleus accumbens (Acb) affect basal Fos-like immunoreactivity (-LI) in terminal regions of th e mesotelencephalic dopamine system. It was hypothesized that dopamine depletion in the Acb would alter activation of mesotelencephalic dopa mine neurons perhaps via the striatomesencephalic GABAergic pathway, a nd that this may be detected as altered basal Fos-LI in mesotelencepha lic terminal regions. 6-OHDA treatment effectively depleted tyrosine h ydroxylase (TH)-LI in well-circumscribed areas of the Acb at 14 days p ost-lesion, but at 25 days post-lesion all animals showed a reappearan ce of TH-LI staining in the lesioned region. When data from a number o f mesotelencephalic terminals regions was pooled, Fos-LI cell density was higher in the sham and lesion 14-day groups and sham 25-day group than both the 25-day lesion group and untreated controls. The present study demonstrates that unilateral sham and 6-OHDA lesions in the Acb may have repercussions throughout the mesotelencephalic dopamine syste m. Further investigation is necessary to determine whether reappearanc e of TH-LI at the lesion site contributes to the return of Fos-LI to b asal levels.